Renal Cancer - Results from #320

Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups. June 4, 2024

Current surgical approaches to pediatric renal tumors. June 3, 2024

Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. June 3, 2024

A Model to Predict Prognosis of Renal Cell Clear Cell Carcinoma Based on 3 Angiogenesis-related Long Non-coding RNAs. June 3, 2024

Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma. May 31, 2024

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. May 31, 2024

Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review. May 31, 2024

Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches. May 30, 2024

CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway. May 30, 2024

Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review. May 30, 2024

Preoperative Super-Selective Embolization versus "On-Clamp" Laparoscopic Partial Nephrectomy for T1 Renal Tumors- A Prospective Randomized Study. May 29, 2024

Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration. May 29, 2024

Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis. May 29, 2024

Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial. May 28, 2024

Targeting apoptosis in clear cell renal cell carcinoma. May 28, 2024

Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. May 27, 2024

Characterization of FOLH1 Expression in Renal Cell Carcinoma. May 27, 2024

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances. May 24, 2024

Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies. May 24, 2024

Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma. May 23, 2024

Page 17 of 456